Applying competing risks analysis to recurrences of primary breast cancer

被引:0
|
作者
Mancini, Silvia [1 ]
Biggeri, Annibale [2 ]
Giuliani, Orietta [1 ]
Vattiato, Rosa [1 ]
Baldacchini, Flavia [1 ]
Ravaioli, Alessandra [1 ]
Zamagni, Federica [1 ]
Falcini, Fabio [1 ,3 ]
Bucchi, Lauro [1 ]
机构
[1] IRCCS Ist Romagnolo Tumori IRST Dino Amadori, Romagna Canc Inst, Emilia Romagna Canc Registry, Romagna Unit, Forli, Italy
[2] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Unit Biostat Epidemiol & Publ Hlth, Padua, Italy
[3] Local Hlth Author, Canc Prevent Unit, Forli, Italy
来源
EPIDEMIOLOGIA & PREVENZIONE | 2023年 / 47卷 / 06期
关键词
breast cancer; recurrence; competing risks;
D O I
10.19191/EP23.6.A600.084
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: in time-to-event analysis, competing risks are observed when a subject is at risk of multiple types of events. A competing risk is an event that prevents the event of interest from happening or modifies its chance to occur. Objectives: the purposes of this article are to provide an overview of competing risks analysis and to illustrate its application to the follow-up of breast cancer patients in order to estimate the risk of disease recurrence. Design: cohort study. Setting and participants: population-based random sample of patients with stage I-III primary female breast cancer diagnosed in 2000-2013, aged 15 years or older, resident in the Forli health care district ( northern Italy), treated surgically and with available information regarding disease laterality. Main outcome measures: subhazard ratio, hazard ratio and cumulative incidence function for loco-regional recurrences and distant metastasis during 10 years of follow-up. Methods: breast cancer recurrences were evaluated taking into account death from any cause and occurrence of a second primary breast cancer as competing risks. Recent developments in competing risks methodology were used. The results obtained were compared with those from the Cox regression model, in which the competing risks were not accounted for. Conclusions: estimating the risk of recurrence without accounting for the competing risks resulted in a divergence of the hazard/subhazard functions. Competing risks analysis is preferable when the statistical assumption of independence of end-points may be violated.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 50 条
  • [21] Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups
    Zhang, Shengfan
    Ivy, Julie S.
    Wilson, James R.
    Diehl, Kathleen M.
    Yankaskas, Bonnie C.
    HEALTH CARE MANAGEMENT SCIENCE, 2014, 17 (03) : 259 - 269
  • [22] New insight into epirubicin cardiac toxicity: Competing risks analysis of 1097 breast cancer patients
    Ryberg, Marianne
    Nielsen, Dorte
    Cortese, Giuliana
    Nielsen, Gitte
    Skovsgaard, Torben
    Andersen, Per Kragh
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (15): : 1058 - 1067
  • [23] A competing risks analysis of the association between prediagnostic serum glucose and lipids and breast cancer survival
    Wulaningsih, W.
    Vandaninia, M.
    Rowley, M.
    Holmberg, L.
    Garmo, H.
    Malmstrom, H.
    Lambe, M.
    Hammar, N.
    Walldius, G.
    Jungner, I.
    Coolen, A.
    Van Hemelrijck, M.
    CANCER RESEARCH, 2016, 76
  • [24] Competing risks analysis in mortality estimation for breast cancer patients from independent risk groups
    Shengfan Zhang
    Julie S. Ivy
    James R. Wilson
    Kathleen M. Diehl
    Bonnie C. Yankaskas
    Health Care Management Science, 2014, 17 : 259 - 269
  • [25] Competing risks of death in younger and older postmenopausal breast cancer patients
    Chapman, Judy-Anne W.
    Pritchard, Kathleen, I
    Goss, Paul E.
    Ingle, James N.
    Muss, Hyman B.
    Dent, Susan F.
    Vandenberg, Ted A.
    Findlay, Brian
    Gelmon, Karen A.
    Wilson, Carolyn F.
    Shepherd, Lois E.
    Pollak, Michael N.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (05): : 1088 - 1096
  • [26] Decision Tree for Competing Risks Survival Probability in Breast Cancer Study
    Ibrahim, N. A.
    Kudus, A.
    Daud, I.
    Abu Bakar, M. R.
    PROCEEDINGS OF WORLD ACADEMY OF SCIENCE, ENGINEERING AND TECHNOLOGY, VOL 28, 2008, 28 : 15 - +
  • [27] RECURRENCES AND METASTASES IN CANCER OF THE BREAST - AN ANALYSIS OF 100 CASES
    HOFFERT, PW
    PENDERGRASS, EP
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1953, 70 (03) : 376 - 386
  • [28] LOCOREGIONAL INTRAARTERIAL CHEMOTHERAPY IN PRIMARY INCURABLE BREAST-CANCER RECURRENCES
    NITZ, U
    HAVENITH, B
    ROST, B
    MOSNY, D
    ELLERBROK, G
    GEBURTSHILFE UND FRAUENHEILKUNDE, 1993, 53 (11) : 760 - 767
  • [29] Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis
    W. L. Lu
    L. Jansen
    W. J. Post
    J. Bonnema
    J. C. Van de Velde
    G. H. De Bock
    Breast Cancer Research and Treatment, 2009, 114
  • [30] Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis
    Lu, W. L.
    Jansen, L.
    Post, W. J.
    Bonnema, J.
    Van de Velde, J. C.
    De Bock, G. H.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 403 - 412